Related Experiment Video
Updated: Oct 8, 2025

Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors
Published on: December 11, 2021
Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors
Artem Eremeev1, Lilia Belikova2, Evgeny Ruchko3
1Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency.
This study introduces a novel, cost-effective mini bioreactor protocol for generating consistent, high-quality induced pluripotent stem cell-derived brain organoids, improving nervous system modeling and drug screening capabilities.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Biotechnology
Background:
- Induced pluripotent stem cell (iPSC)-derived brain organoids offer a powerful in vitro model for studying nervous system diseases and facilitating drug discovery.
- Current protocols face limitations in consistency, lengthy maturation times (up to a year), and scalability, hindering widespread preclinical applications.
- Existing methods often result in central necrotic zones due to nutrient/oxygen deficiency, necessitating complex culture systems.
Purpose of the Study:
- To develop an improved protocol for generating consistent, high-quality iPSC-derived brain organoids.
- To address the limitations of current organoid maturation times and scalability.
- To create a cost-effective and accessible method for large-scale organoid production.
Main Methods:
- Development of compact, inexpensive, home-made mini bioreactors for brain organoid cultivation.
- Implementation of a novel protocol optimizing organoid growth and maturation within these bioreactors.
- Focus on overcoming nutrient and oxygen deficiency issues common in current brain organoid models.
Main Results:
- Successful production of high-quality brain organoids using the developed mini bioreactor system.
- Demonstration of consistency in organoid generation, suitable for drug discovery applications.
- Significant reduction in costs and space requirements compared to existing methods.
Conclusions:
- The novel mini bioreactor protocol provides a scalable, cost-effective solution for producing consistent iPSC-derived brain organoids.
- This advancement enhances the utility of brain organoids for in vitro modeling of neurological disorders and preclinical drug screening.
- The developed system overcomes key limitations, paving the way for more reliable and accessible neuroscience research.

